Since our analysis demonstrated that the GNAS mutation was specific to IPMN, the associations between the selected clinical variables and GNAS status in the 82 IPMN cases were statistically analysed to clarify the clinical relevance and importance of the GNAS mutation in the pancreatic juice. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.